David Brook
academic
David Brook collaborated with Peter Singer on modeling the effects of global access to GLP-1 medicines, which highlight the potential to save millions of lives annually from diabetes and obesity-related complications.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
In a preprint estimate in collaboration with David Brook, Dr. Singer modelled the effects of global access to these GLP-1 medicines.
6